Download PDF
Thromb Haemost 2002; 87(05): 920-921
DOI: 10.1055/s-0037-1613109
Letters to the Editor
Schattauer GmbH

The Tissue Factor Pathway Inhibitor C536T Mutation is not Associated with the Risk of Stroke in Young Adults

R. Junker
1   Institut für Arterioskleroseforschung, Uniklinikum Miinster
,
J. Glahn
2   Klinik für Neurologie, Stadtisches Krankenhaus Minden
,
N. Tidow
3   Institut für Klinische Chemie und Laboratoriumsmedizin, Uniklinikum Münster
,
T. Brinkmann
4   Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitatsklinik der Ruhr-Universitat Bochum, Bad Oeynhausen
,
D.G. Nabavi
5   Klinik und Poliklinik fiir Neurologie, Uniklinikum Miinster, Germany
› Author Affiliations
Further Information

Publication History

Received 10 September 2001

Accepted after resubmission 12 September 2001

Publication Date:
11 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Kleesiek K, Schmidt M, Gotting C, Brinkmann T, Prohaska W. A first mutation in the human tissue factor pathway inhibitor gene encoding (P151L)TFPI (letter). Blood 1998; 92: 3976-7.
    PubMedGoogle Scholar
  • 2 Kleesiek K, Schmidt M, Gotting C, Schwenz B, Lange S, Muller-Berghaus G, Brinkmann T, Prohaska W. The 536C-➔T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis. Thromb Haemost 1999; 82: 1-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Paciaroni K, Rossi E, Bazzan M, Ireland H, De Stefano V. Prevalence of the C536T mutation in the tissue factor pathway inhibitor (TFPI) gene among patients with venous thromboembolic disease. Thromb Haemost (letter) 2001; 85: 938-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Hessner MJ, Luhm RA. The C536T transition in the tissue factor pathway inhibitor (TFPI) gene does not contribute to risk of venous thrombosis among carriers of factor V Leiden. Thromb Haemost (letter) 2000; 84: 724-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Evans GD, Langdown J, Brown K, Baglin TP. The C536T transition in the tissue factor pathway inhibitor gene is not a common cause of venous thromboembolic disease in the UK population. Thromb Haemost (letter) 2000; 83: 511.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Gonzalez-Conejero R, Lozano ML, Corral J, Martinez C, Vicente V. The TFPI 536C-➔T mutation is not associated with increased risk for venous or arterial thrombosis (letter). Thromb Haemost 2000; 83: 787-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54: 541-53.
    PubMedGoogle Scholar